img

Global Generic Active Pharmaceutical Ingredients Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Generic Active Pharmaceutical Ingredients Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Generic Active Pharmaceutical Ingredients report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Generic Active Pharmaceutical Ingredients market is projected to reach US$ 16040 million in 2034, increasing from US$ 10800 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2034. Demand from Oncology and Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Generic Active Pharmaceutical Ingredients industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Generic Active Pharmaceutical Ingredients key manufacturers include Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), Boehringer Ingelheim (Germany), Bristol-Myers Squibb (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Eli Lilly and Company (U.S.), GlaxoSmithKline plc (U.K.) and Merck & Co., Inc. (U.S.), etc. Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France) are top 3 players and held % sales share in total in 2022.
Generic Active Pharmaceutical Ingredients can be divided into Monoclonal Antibodies, Hormones, Cytokines and Fusion Proteins, etc. Monoclonal Antibodies is the mainstream product in the market, accounting for % sales share globally in 2022.
Generic Active Pharmaceutical Ingredients is widely used in various fields, such as Oncology, Diabetes, Cardiovascular Disease and CNS and Neurological Disorders, etc. Oncology provides greatest supports to the Generic Active Pharmaceutical Ingredients industry development. In 2022, global % sales of Generic Active Pharmaceutical Ingredients went into Oncology filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Generic Active Pharmaceutical Ingredients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Pfizer, Inc. (U.S.)
Novartis International AG (Switzerland)
Sanofi (France)
Boehringer Ingelheim (Germany)
Bristol-Myers Squibb (U.S.)
Teva Pharmaceutical Industries Ltd. (Israel)
Eli Lilly and Company (U.S.)
GlaxoSmithKline plc (U.K.)
Merck & Co., Inc. (U.S.)
AbbVie Inc. (U.S.)
Segment by Type
Monoclonal Antibodies
Hormones
Cytokines
Fusion Proteins
Therapeutic Enzymes
Vaccines
Blood Factors

Segment by Application


Oncology
Diabetes
Cardiovascular Disease
CNS and Neurological Disorders
Endocrinology
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Generic Active Pharmaceutical Ingredients market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Generic Active Pharmaceutical Ingredients, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Generic Active Pharmaceutical Ingredients industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Generic Active Pharmaceutical Ingredients in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Generic Active Pharmaceutical Ingredients introduction, etc. Generic Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Generic Active Pharmaceutical Ingredients market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Generic Active Pharmaceutical Ingredients Market Overview
1.1 Generic Active Pharmaceutical Ingredients Product Overview
1.2 Generic Active Pharmaceutical Ingredients Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Hormones
1.2.3 Cytokines
1.2.4 Fusion Proteins
1.2.5 Therapeutic Enzymes
1.2.6 Vaccines
1.2.7 Blood Factors
1.3 Global Generic Active Pharmaceutical Ingredients Market Size by Type
1.3.1 Global Generic Active Pharmaceutical Ingredients Market Size Overview by Type (2018-2034)
1.3.2 Global Generic Active Pharmaceutical Ingredients Historic Market Size Review by Type (2018-2024)
1.3.3 Global Generic Active Pharmaceutical Ingredients Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Generic Active Pharmaceutical Ingredients Sales Breakdown by Type (2018-2024)
1.4.2 Europe Generic Active Pharmaceutical Ingredients Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Generic Active Pharmaceutical Ingredients Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Breakdown by Type (2018-2024)
2 Global Generic Active Pharmaceutical Ingredients Market Competition by Company
2.1 Global Top Players by Generic Active Pharmaceutical Ingredients Sales (2018-2024)
2.2 Global Top Players by Generic Active Pharmaceutical Ingredients Revenue (2018-2024)
2.3 Global Top Players by Generic Active Pharmaceutical Ingredients Price (2018-2024)
2.4 Global Top Manufacturers Generic Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area, Product Type
2.5 Generic Active Pharmaceutical Ingredients Market Competitive Situation and Trends
2.5.1 Generic Active Pharmaceutical Ingredients Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Generic Active Pharmaceutical Ingredients Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Active Pharmaceutical Ingredients as of 2022)
2.7 Date of Key Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
2.8 Key Manufacturers Generic Active Pharmaceutical Ingredients Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Generic Active Pharmaceutical Ingredients Status and Outlook by Region
3.1 Global Generic Active Pharmaceutical Ingredients Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Generic Active Pharmaceutical Ingredients Historic Market Size by Region
3.2.1 Global Generic Active Pharmaceutical Ingredients Sales in Volume by Region (2018-2024)
3.2.2 Global Generic Active Pharmaceutical Ingredients Sales in Value by Region (2018-2024)
3.2.3 Global Generic Active Pharmaceutical Ingredients Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Generic Active Pharmaceutical Ingredients Forecasted Market Size by Region
3.3.1 Global Generic Active Pharmaceutical Ingredients Sales in Volume by Region (2024-2034)
3.3.2 Global Generic Active Pharmaceutical Ingredients Sales in Value by Region (2024-2034)
3.3.3 Global Generic Active Pharmaceutical Ingredients Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Generic Active Pharmaceutical Ingredients by Application
4.1 Generic Active Pharmaceutical Ingredients Market Segment by Application
4.1.1 Oncology
4.1.2 Diabetes
4.1.3 Cardiovascular Disease
4.1.4 CNS and Neurological Disorders
4.1.5 Endocrinology
4.1.6 Others
4.2 Global Generic Active Pharmaceutical Ingredients Market Size by Application
4.2.1 Global Generic Active Pharmaceutical Ingredients Market Size Overview by Application (2018-2034)
4.2.2 Global Generic Active Pharmaceutical Ingredients Historic Market Size Review by Application (2018-2024)
4.2.3 Global Generic Active Pharmaceutical Ingredients Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Generic Active Pharmaceutical Ingredients Sales Breakdown by Application (2018-2024)
4.3.2 Europe Generic Active Pharmaceutical Ingredients Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Generic Active Pharmaceutical Ingredients Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Breakdown by Application (2018-2024)
5 North America Generic Active Pharmaceutical Ingredients by Country
5.1 North America Generic Active Pharmaceutical Ingredients Historic Market Size by Country
5.1.1 North America Generic Active Pharmaceutical Ingredients Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2018-2024)
5.1.3 North America Generic Active Pharmaceutical Ingredients Sales in Value by Country (2018-2024)
5.2 North America Generic Active Pharmaceutical Ingredients Forecasted Market Size by Country
5.2.1 North America Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2024-2034)
5.2.2 North America Generic Active Pharmaceutical Ingredients Sales in Value by Country (2024-2034)
6 Europe Generic Active Pharmaceutical Ingredients by Country
6.1 Europe Generic Active Pharmaceutical Ingredients Historic Market Size by Country
6.1.1 Europe Generic Active Pharmaceutical Ingredients Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2018-2024)
6.1.3 Europe Generic Active Pharmaceutical Ingredients Sales in Value by Country (2018-2024)
6.2 Europe Generic Active Pharmaceutical Ingredients Forecasted Market Size by Country
6.2.1 Europe Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2024-2034)
6.2.2 Europe Generic Active Pharmaceutical Ingredients Sales in Value by Country (2024-2034)
7 Asia-Pacific Generic Active Pharmaceutical Ingredients by Region
7.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Historic Market Size by Region
7.1.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Generic Active Pharmaceutical Ingredients Forecasted Market Size by Region
7.2.1 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Generic Active Pharmaceutical Ingredients Sales in Value by Region (2024-2034)
8 Latin America Generic Active Pharmaceutical Ingredients by Country
8.1 Latin America Generic Active Pharmaceutical Ingredients Historic Market Size by Country
8.1.1 Latin America Generic Active Pharmaceutical Ingredients Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2018-2024)
8.1.3 Latin America Generic Active Pharmaceutical Ingredients Sales in Value by Country (2018-2024)
8.2 Latin America Generic Active Pharmaceutical Ingredients Forecasted Market Size by Country
8.2.1 Latin America Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2024-2034)
8.2.2 Latin America Generic Active Pharmaceutical Ingredients Sales in Value by Country (2024-2034)
9 Middle East and Africa Generic Active Pharmaceutical Ingredients by Country
9.1 Middle East and Africa Generic Active Pharmaceutical Ingredients Historic Market Size by Country
9.1.1 Middle East and Africa Generic Active Pharmaceutical Ingredients Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Forecasted Market Size by Country
9.2.1 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Generic Active Pharmaceutical Ingredients Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer, Inc. (U.S.)
10.1.1 Pfizer, Inc. (U.S.) Company Information
10.1.2 Pfizer, Inc. (U.S.) Introduction and Business Overview
10.1.3 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
10.1.5 Pfizer, Inc. (U.S.) Recent Development
10.2 Novartis International AG (Switzerland)
10.2.1 Novartis International AG (Switzerland) Company Information
10.2.2 Novartis International AG (Switzerland) Introduction and Business Overview
10.2.3 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Products Offered
10.2.5 Novartis International AG (Switzerland) Recent Development
10.3 Sanofi (France)
10.3.1 Sanofi (France) Company Information
10.3.2 Sanofi (France) Introduction and Business Overview
10.3.3 Sanofi (France) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Sanofi (France) Generic Active Pharmaceutical Ingredients Products Offered
10.3.5 Sanofi (France) Recent Development
10.4 Boehringer Ingelheim (Germany)
10.4.1 Boehringer Ingelheim (Germany) Company Information
10.4.2 Boehringer Ingelheim (Germany) Introduction and Business Overview
10.4.3 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Products Offered
10.4.5 Boehringer Ingelheim (Germany) Recent Development
10.5 Bristol-Myers Squibb (U.S.)
10.5.1 Bristol-Myers Squibb (U.S.) Company Information
10.5.2 Bristol-Myers Squibb (U.S.) Introduction and Business Overview
10.5.3 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
10.5.5 Bristol-Myers Squibb (U.S.) Recent Development
10.6 Teva Pharmaceutical Industries Ltd. (Israel)
10.6.1 Teva Pharmaceutical Industries Ltd. (Israel) Company Information
10.6.2 Teva Pharmaceutical Industries Ltd. (Israel) Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Products Offered
10.6.5 Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
10.7 Eli Lilly and Company (U.S.)
10.7.1 Eli Lilly and Company (U.S.) Company Information
10.7.2 Eli Lilly and Company (U.S.) Introduction and Business Overview
10.7.3 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
10.7.5 Eli Lilly and Company (U.S.) Recent Development
10.8 GlaxoSmithKline plc (U.K.)
10.8.1 GlaxoSmithKline plc (U.K.) Company Information
10.8.2 GlaxoSmithKline plc (U.K.) Introduction and Business Overview
10.8.3 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.8.4 GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Products Offered
10.8.5 GlaxoSmithKline plc (U.K.) Recent Development
10.9 Merck & Co., Inc. (U.S.)
10.9.1 Merck & Co., Inc. (U.S.) Company Information
10.9.2 Merck & Co., Inc. (U.S.) Introduction and Business Overview
10.9.3 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
10.9.5 Merck & Co., Inc. (U.S.) Recent Development
10.10 AbbVie Inc. (U.S.)
10.10.1 AbbVie Inc. (U.S.) Company Information
10.10.2 AbbVie Inc. (U.S.) Introduction and Business Overview
10.10.3 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales, Revenue and Gross Margin (2018-2024)
10.10.4 AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Products Offered
10.10.5 AbbVie Inc. (U.S.) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Generic Active Pharmaceutical Ingredients Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Generic Active Pharmaceutical Ingredients Industrial Chain Analysis
11.4 Generic Active Pharmaceutical Ingredients Market Dynamics
11.4.1 Generic Active Pharmaceutical Ingredients Industry Trends
11.4.2 Generic Active Pharmaceutical Ingredients Market Drivers
11.4.3 Generic Active Pharmaceutical Ingredients Market Challenges
11.4.4 Generic Active Pharmaceutical Ingredients Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Generic Active Pharmaceutical Ingredients Distributors
12.3 Generic Active Pharmaceutical Ingredients Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibodies
Table 2. Major Company of Hormones
Table 3. Major Company of Cytokines
Table 4. Major Company of Fusion Proteins
Table 5. Major Company of Therapeutic Enzymes
Table 6. Major Company of Vaccines
Table 7. Major Company of Blood Factors
Table 8. Global Generic Active Pharmaceutical Ingredients Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 9. Global Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (K MT)
Table 10. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type (2018-2024)
Table 11. Global Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (US& Million)
Table 12. Global Generic Active Pharmaceutical Ingredients Market Share in Value by Type (2018-2024)
Table 13. Global Generic Active Pharmaceutical Ingredients Price by Type (2018-2024) & (USD/MT)
Table 14. Global Generic Active Pharmaceutical Ingredients Sales by Type (2024-2034) & (K MT)
Table 15. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type (2024-2034)
Table 16. Global Generic Active Pharmaceutical Ingredients Sales by Type (2024-2034) & (US$ Million)
Table 17. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Type (2024-2034)
Table 18. Global Generic Active Pharmaceutical Ingredients Price by Type (2024-2034) & (USD/MT)
Table 19. North America Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (K MT)
Table 20. North America Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (US$ Million)
Table 21. Europe Generic Active Pharmaceutical Ingredients Sales (K MT) by Type (2018-2024)
Table 22. Europe Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (US$ Million)
Table 23. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales (K MT) by Type (2018-2024)
Table 24. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (US$ Million)
Table 25. Latin America Generic Active Pharmaceutical Ingredients Sales (K MT) by Type (2018-2024)
Table 26. Latin America Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (US$ Million)
Table 27. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales (K MT) by Type (2018-2024)
Table 28. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Type (2018-2024) & (US$ Million)
Table 29. Global Generic Active Pharmaceutical Ingredients Sales by Company (2018-2024) & (K MT)
Table 30. Global Generic Active Pharmaceutical Ingredients Sales Share by Company (2018-2024)
Table 31. Global Generic Active Pharmaceutical Ingredients Revenue by Company (2018-2024) & (US$ Million)
Table 32. Global Generic Active Pharmaceutical Ingredients Revenue Share by Company (2018-2024)
Table 33. Global Market Generic Active Pharmaceutical Ingredients Price by Company (2018-2024) & (USD/MT)
Table 34. Global Generic Active Pharmaceutical Ingredients Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global Generic Active Pharmaceutical Ingredients Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Generic Active Pharmaceutical Ingredients as of 2022)
Table 37. Date of Key Manufacturers Enter into Generic Active Pharmaceutical Ingredients Market
Table 38. Key Manufacturers Generic Active Pharmaceutical Ingredients Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global Generic Active Pharmaceutical Ingredients Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 41. Global Generic Active Pharmaceutical Ingredients Sales by Region (2018-2024) & (K MT)
Table 42. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Region (2018-2024)
Table 43. Global Generic Active Pharmaceutical Ingredients Sales by Region (2018-2024) & (US$ Million)
Table 44. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Region (2018-2024)
Table 45. Global Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 46. Global Generic Active Pharmaceutical Ingredients Sales by Region (2024-2034) & (K MT)
Table 47. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Region (2024-2034)
Table 48. Global Generic Active Pharmaceutical Ingredients Sales by Region (2024-2034) & (US$ Million)
Table 49. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Region (2024-2034)
Table 50. Global Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 51. Global Generic Active Pharmaceutical Ingredients Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 52. Global Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (K MT)
Table 53. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Application (2018-2024)
Table 54. Global Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (US$ Million)
Table 55. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application (2018-2024)
Table 56. Global Generic Active Pharmaceutical Ingredients Price by Application (2018-2024) & (USD/MT)
Table 57. Global Generic Active Pharmaceutical Ingredients Sales by Application (2024-2034) & (K MT)
Table 58. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Application (2024-2034)
Table 59. Global Generic Active Pharmaceutical Ingredients Sales by Application (2024-2034) & (US$ Million)
Table 60. Global Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application (2024-2034)
Table 61. Global Generic Active Pharmaceutical Ingredients Price by Application (2024-2034) & (USD/MT)
Table 62. North America Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) (K MT)
Table 63. North America Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (US$ Million)
Table 64. Europe Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) (K MT)
Table 65. Europe Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (US$ Million)
Table 66. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) (K MT)
Table 67. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (US$ Million)
Table 68. Latin America Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) (K MT)
Table 69. Latin America Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (US$ Million)
Table 70. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) (K MT)
Table 71. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Application (2018-2024) & (US$ Million)
Table 72. North America Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (K MT)
Table 73. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2018-2024)
Table 74. North America Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (US$ Million)
Table 75. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2018-2024)
Table 76. North America Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (K MT)
Table 77. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2024-2034)
Table 78. North America Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (US$ Million)
Table 79. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2024-2034)
Table 80. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (K MT)
Table 81. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2018-2024)
Table 82. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (US$ Million)
Table 83. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2018-2024)
Table 84. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (K MT)
Table 85. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2018-2024) & (K MT)
Table 89. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Region (2018-2024)
Table 90. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2018-2024) & (US$ Million)
Table 91. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Region (2018-2024)
Table 92. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2024-2034) & (K MT)
Table 93. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (K MT)
Table 97. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2018-2024)
Table 98. Latin America Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (US$ Million)
Table 99. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2018-2024)
Table 100. Latin America Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (K MT)
Table 101. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (K MT)
Table 105. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2018-2024)
Table 106. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country (2018-2024) & (US$ Million)
Table 107. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2018-2024)
Table 108. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (K MT)
Table 109. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Country (2024-2034)
Table 112. Pfizer, Inc. (U.S.) Company Information
Table 113. Pfizer, Inc. (U.S.) Introduction and Business Overview
Table 114. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 115. Pfizer, Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product
Table 116. Pfizer, Inc. (U.S.) Recent Development
Table 117. Novartis International AG (Switzerland) Company Information
Table 118. Novartis International AG (Switzerland) Introduction and Business Overview
Table 119. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 120. Novartis International AG (Switzerland) Generic Active Pharmaceutical Ingredients Product
Table 121. Novartis International AG (Switzerland) Recent Development
Table 122. Sanofi (France) Company Information
Table 123. Sanofi (France) Introduction and Business Overview
Table 124. Sanofi (France) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 125. Sanofi (France) Generic Active Pharmaceutical Ingredients Product
Table 126. Sanofi (France) Recent Development
Table 127. Boehringer Ingelheim (Germany) Company Information
Table 128. Boehringer Ingelheim (Germany) Introduction and Business Overview
Table 129. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 130. Boehringer Ingelheim (Germany) Generic Active Pharmaceutical Ingredients Product
Table 131. Boehringer Ingelheim (Germany) Recent Development
Table 132. Bristol-Myers Squibb (U.S.) Company Information
Table 133. Bristol-Myers Squibb (U.S.) Introduction and Business Overview
Table 134. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 135. Bristol-Myers Squibb (U.S.) Generic Active Pharmaceutical Ingredients Product
Table 136. Bristol-Myers Squibb (U.S.) Recent Development
Table 137. Teva Pharmaceutical Industries Ltd. (Israel) Company Information
Table 138. Teva Pharmaceutical Industries Ltd. (Israel) Introduction and Business Overview
Table 139. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 140. Teva Pharmaceutical Industries Ltd. (Israel) Generic Active Pharmaceutical Ingredients Product
Table 141. Teva Pharmaceutical Industries Ltd. (Israel) Recent Development
Table 142. Eli Lilly and Company (U.S.) Company Information
Table 143. Eli Lilly and Company (U.S.) Introduction and Business Overview
Table 144. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 145. Eli Lilly and Company (U.S.) Generic Active Pharmaceutical Ingredients Product
Table 146. Eli Lilly and Company (U.S.) Recent Development
Table 147. GlaxoSmithKline plc (U.K.) Company Information
Table 148. GlaxoSmithKline plc (U.K.) Introduction and Business Overview
Table 149. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 150. GlaxoSmithKline plc (U.K.) Generic Active Pharmaceutical Ingredients Product
Table 151. GlaxoSmithKline plc (U.K.) Recent Development
Table 152. Merck & Co., Inc. (U.S.) Company Information
Table 153. Merck & Co., Inc. (U.S.) Introduction and Business Overview
Table 154. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 155. Merck & Co., Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product
Table 156. Merck & Co., Inc. (U.S.) Recent Development
Table 157. AbbVie Inc. (U.S.) Company Information
Table 158. AbbVie Inc. (U.S.) Introduction and Business Overview
Table 159. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 160. AbbVie Inc. (U.S.) Generic Active Pharmaceutical Ingredients Product
Table 161. AbbVie Inc. (U.S.) Recent Development
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Generic Active Pharmaceutical Ingredients Market Trends
Table 165. Generic Active Pharmaceutical Ingredients Market Drivers
Table 166. Generic Active Pharmaceutical Ingredients Market Challenges
Table 167. Generic Active Pharmaceutical Ingredients Market Restraints
Table 168. Generic Active Pharmaceutical Ingredients Distributors List
Table 169. Generic Active Pharmaceutical Ingredients Downstream Customers
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Generic Active Pharmaceutical Ingredients Product Picture
Figure 2. Global Generic Active Pharmaceutical Ingredients Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Generic Active Pharmaceutical Ingredients Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Generic Active Pharmaceutical Ingredients Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Monoclonal Antibodies
Figure 6. Global Monoclonal Antibodies Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Hormones
Figure 8. Global Hormones Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Cytokines
Figure 10. Global Cytokines Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Product Picture of Fusion Proteins
Figure 12. Global Fusion Proteins Sales YoY Growth (2018-2034) & (K MT)
Figure 13. Product Picture of Therapeutic Enzymes
Figure 14. Global Therapeutic Enzymes Sales YoY Growth (2018-2034) & (K MT)
Figure 15. Product Picture of Vaccines
Figure 16. Global Vaccines Sales YoY Growth (2018-2034) & (K MT)
Figure 17. Product Picture of Blood Factors
Figure 18. Global Blood Factors Sales YoY Growth (2018-2034) & (K MT)
Figure 19. Global Generic Active Pharmaceutical Ingredients Sales by Type (2018-2034) & (US$ Million)
Figure 20. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Type in 2022 & 2034
Figure 21. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type in 2022
Figure 22. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Type in 2022
Figure 23. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type in 2022
Figure 24. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Type in 2022
Figure 27. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type in 2022
Figure 28. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Generic Active Pharmaceutical Ingredients Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by Generic Active Pharmaceutical Ingredients Revenue in 2022
Figure 33. Generic Active Pharmaceutical Ingredients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Product Picture of Oncology
Figure 35. Global Oncology Sales YoY Growth (2018-2034) & (K MT)
Figure 36. Product Picture of Diabetes
Figure 37. Global Diabetes Sales YoY Growth (2018-2034) & (K MT)
Figure 38. Product Picture of Cardiovascular Disease
Figure 39. Global Cardiovascular Disease Sales YoY Growth (2018-2034) & (K MT)
Figure 40. Product Picture of CNS and Neurological Disorders
Figure 41. Global CNS and Neurological Disorders Sales YoY Growth (2018-2034) & (K MT)
Figure 42. Product Picture of Endocrinology
Figure 43. Global Endocrinology Sales YoY Growth (2018-2034) & (K MT)
Figure 44. Product Picture of Others
Figure 45. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 46. Global Generic Active Pharmaceutical Ingredients Sales by Application (2018-2034) & (US$ Million)
Figure 47. Global Generic Active Pharmaceutical Ingredients Sales Market Share by Application in 2022 & 2034
Figure 48. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Application in 2022
Figure 49. North America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application in 2022
Figure 50. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Application in 2022
Figure 51. Europe Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application in 2022
Figure 52. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Application in 2022
Figure 53. Asia-Pacific Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application in 2022
Figure 54. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Volume by Application in 2022
Figure 55. Latin America Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application in 2022
Figure 56. Middle East and Africa Generic Active Pharmaceutical Ingredients Sales Market Share in Value by Application in 2022
Figure 57. Key Raw Materials Price
Figure 58. Generic Active Pharmaceutical Ingredients Manufacturing Cost Structure
Figure 59. Generic Active Pharmaceutical Ingredients Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries